Products » Oncology Products_碧康制药股份有限公司

Sunitinib (Sunitix)

SUNITIX, an oral multi-kinase inhibitor, is the malate salt of sunitinib. Sunitinib malate is described chemically as Butanedioic acid, hydroxy-, (2S)-, compound with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro1,2-dihydro-2-oxo-3H-indol-3-yl

Sorafenib (Soranix)

SORANIX, a kinase inhibitor, is the tosylate salt of sorafenib. Sorafenib tosylate has the chemical name 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)N2methylpyridine-2-carboxamide 4-methylbenzenesulfonate.

Rituximab (Rituxim)

The Rituximab antibody is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes.

Pemetrexed (Pemetrex)

Pemetrexed disodium heptahydrate has the chemical name L- Glutamic acid , N-[4-[2-(2-amino-4,7-dihydro-4-oxo1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt, heptahydrate. It is a white to almost-white solid with a molecular f

Pegylated filgrastim (Pegfilgrast)

Pegfilgrastim is a covalent conjugate of recombinant methionyl human G-CSF (Filgrastim)

Paclitaxel (Xelpac)

Xelpac (paclitaxel) Injection is a clear, colorless to slightly yellow viscous solution. It is supplied as a nonaqueous solution intended for dilution with a suitable parenteral fluid prior to intravenous infusion. Xelpac is available in 30